Literature DB >> 21511367

Ventilator-associated pneumonia in intensive care units in Hubei Province, China: a multicentre prospective cohort survey.

Duo-shuang Xie1, Wei Xiong, Rui-ping Lai, Li Liu, Xiu-min Gan, Xiao-hui Wang, Min Wang, Yuan-xia Lou, Xiang-yun Fu, Hui-fang Wang, Hao Xiang, Yi-hua Xu, Shao-fa Nie.   

Abstract

A multicentre prospective cohort study was performed in 17 intensive care units (ICUs) in tertiary care hospitals in Hubei Province, China. Ventilator-associated pneumonia (VAP) was defined according to modified criteria from the published literature. Among 4155 ventilated patients, the crude incidence and incidence rate of VAP were 20.9% and 28.9 cases per 1000 ventilator-days. Multivariate analysis using logistic regression revealed risk factors including male sex [risk ratio (RR): 1.5; P<0.001], coma (RR: 2.1; P<0.001), chronic obstructive pulmonary disease (RR: 1.4; P<0.001), infections at other sites (RR: 1.6; P=0.001), serious disease predating the onset of VAP (RR: 1.6; P<0.001) and interventions including antacid treatment (RR: 1.4; P<0.001), antimicrobial treatment (RR: 5.1; P<0.001), bronchoscopy (RR: 1.5; P=0.041) and tracheostomy (RR: 1.4; P=0.014). The most frequently isolated causative pathogens were Pseudomonas aeruginosa and Acinetobacter baumannii. Of all Staphylococcus aureus isolates, 45.7% were meticillin resistant. Rates, risk factors and causal pathogens of VAP in ICUs in Hubei differ from those reported from developed countries. These data show the need for more effective infection control interventions in Hubei, China.
Copyright © 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511367     DOI: 10.1016/j.jhin.2011.03.009

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  20 in total

1.  High-dose ambroxol reduces pulmonary complications in patients with acute cervical spinal cord injury after surgery.

Authors:  Qiang Li; Gaiqi Yao; Xi Zhu
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

2.  Impact of selective digestive decontamination on respiratory tract Candida among patients with suspected ventilator-associated pneumonia. A meta-analysis.

Authors:  J C Hurley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-26       Impact factor: 3.267

3.  COPD patients with ventilator-associated pneumonia: implications for management.

Authors:  D Koulenti; S Blot; J M Dulhunty; L Papazian; I Martin-Loeches; G Dimopoulos; C Brun-Buisson; M Nauwynck; C Putensen; J Sole-Violan; A Armaganidis; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-25       Impact factor: 3.267

4.  A quality assessment of evidence-based guidelines for the prevention and management of ventilator-associated pneumonia: a systematic review.

Authors:  Kairui Wan; Hengrui Liang; Guolin Yan; Bangyu Zou; Chuxin Huang; Mei Jiang
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

5.  A comparison of diagnostic algorithms and clinical parameters to diagnose ventilator-associated pneumonia: a prospective observational study.

Authors:  Farshid Rahimibashar; Andrew C Miller; Mojtaba H Yaghoobi; Amir Vahedian-Azimi
Journal:  BMC Pulm Med       Date:  2021-05-13       Impact factor: 3.317

6.  An assessment of ventilator-associated pneumonias and risk factors identified in the Intensive Care Unit.

Authors:  Mevlut Karatas; Sedat Saylan; Ugur Kostakoglu; Gurdal Yilmaz
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

7.  The effect of ventilator-associated pneumonia on the prognosis of intensive care unit patients within 90 days and 180 days.

Authors:  Wenjuan Luo; Rui Xing; Canmin Wang
Journal:  BMC Infect Dis       Date:  2021-07-15       Impact factor: 3.090

8.  Reducing ventilator-associated pneumonia in neonatal intensive care unit using "VAP prevention Bundle": a cohort study.

Authors:  Seham F A Azab; Hanan S Sherbiny; Safaa H Saleh; Wafaa F Elsaeed; Mona M Elshafiey; Ahmed G Siam; Mohamed A Arafa; Ashgan A Alghobashy; Eman A Bendary; Maha A A Basset; Sanaa M Ismail; Nagwa E Akeel; Nahla A Elsamad; Wesam A Mokhtar; Tarek Gheith
Journal:  BMC Infect Dis       Date:  2015-08-06       Impact factor: 3.090

Review 9.  Antimicrobial resistance in Asia: current epidemiology and clinical implications.

Authors:  Cheol-In Kang; Jae-Hoon Song
Journal:  Infect Chemother       Date:  2013-03-29

10.  A three-year survey of the antimicrobial resistance of microorganisms at a Chinese hospital.

Authors:  Jing Tang; Lili Wang; Yufei Xi; Gaolin Liu
Journal:  Exp Ther Med       Date:  2016-01-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.